| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc. | Chief Medical Officer | Common Stock | 216,585 | $3,170,804 | $14.64 | 13 Aug 2025 | Direct |
| Beam Therapeutics Inc. | Director | Stock Option (Right to Buy) | 33,662 | $563,982 | $24.40 | 04 Jun 2025 | Direct |
| Denali Therapeutics Inc. | Chief Medical Officer | Common Stock | 25,000 | $363,000 | $14.52 | 12 Aug 2025 | Indirect |
| Royalty Pharma plc | Director | Class A Ordinary Shares | 8,558 | $306,718 | $35.84 | 31 Jul 2025 | Direct |
| Denali Therapeutics Inc. | Chief Medical Officer | Stock Option (right to buy) | 62,500 | 05 Aug 2025 | Direct | ||
| NGM BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | 05 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & Co | 31 Dec 2025 | 0 | $0 | 3 | EVP & Pres, Lilly Neuroscience | 06 Jan 2026, 16:13 |
| DNLI | Denali Therapeutics Inc. | 12 Aug 2025 | 2 | -$51,684 | 4 | Chief Medical Officer | 14 Aug 2025, 20:33 |
| DNLI | Denali Therapeutics Inc. | 05 Aug 2025 | 2 | +$30,365 | 4 | Chief Medical Officer | 07 Aug 2025, 17:34 |
| RPRX | Royalty Pharma plc | 31 Jul 2025 | 2 | $0 | 4 | Director | 31 Jul 2025, 20:42 |
| RPRX | Royalty Pharma plc | 17 Jul 2025 | 0 | $0 | 3 | Director | 25 Jul 2025, 16:18 |
| BEAM | Beam Therapeutics Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| DNLI | Denali Therapeutics Inc. | 06 Jan 2025 | 2 | -$308,291 | 4 | Chief Medical Officer | 08 Jan 2025, 20:26 |
| DNLI | Denali Therapeutics Inc. | 03 Jan 2025 | 2 | $0 | 4 | Chief Medical Officer | 07 Jan 2025, 18:56 |
| DNLI | Denali Therapeutics Inc. | 25 Nov 2024 | 2 | +$12,135 | 4 | Chief Medical Officer | 27 Nov 2024, 16:44 |
| DNLI | Denali Therapeutics Inc. | 20 Aug 2024 | 3 | -$549,928 | 4 | Chief Medical Officer | 22 Aug 2024, 16:14 |
| DNLI | Denali Therapeutics Inc. | 13 Aug 2024 | 1 | -$53,494 | 4 | Chief Medical Officer | 15 Aug 2024, 16:09 |
| BEAM | Beam Therapeutics Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:47 |
| /report/000095017024042606-ho-carole-2024-04-05 | NGM BIOPHARMACEUTICALS INC | 05 Apr 2024 | 4 | $0 | 4 | Director | 08 Apr 2024, 16:14 |
| DNLI | Denali Therapeutics Inc. | 13 Feb 2024 | 2 | -$73,130 | 4 | Chief Medical Officer | 15 Feb 2024, 21:14 |
| DNLI | Denali Therapeutics Inc. | 10 Jan 2024 | 1 | -$88,785 | 4 | Chief Medical Officer | 12 Jan 2024, 20:18 |
| DNLI | Denali Therapeutics Inc. | 05 Jan 2024 | 1 | -$193,756 | 4 | Chief Medical Officer | 09 Jan 2024, 19:35 |
| DNLI | Denali Therapeutics Inc. | 03 Jan 2024 | 2 | $0 | 4 | Chief Medical Officer | 05 Jan 2024, 17:57 |
| DNLI | Denali Therapeutics Inc. | 23 Aug 2023 | 1 | -$58,561 | 4 | Chief Medical Officer | 25 Aug 2023, 17:30 |
| DNLI | Denali Therapeutics Inc. | 21 Aug 2023 | 1 | -$56,003 | 4 | Chief Medical Officer | 23 Aug 2023, 16:34 |
| DNLI | Denali Therapeutics Inc. | 14 Aug 2023 | 1 | -$65,851 | 4 | Chief Medical Officer | 16 Aug 2023, 18:20 |
| DNLI | Denali Therapeutics Inc. | 10 Aug 2023 | 1 | -$68,997 | 4 | Chief Medical Officer | 14 Aug 2023, 17:12 |
| BEAM | Beam Therapeutics Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:49 |
| /report/000120919123029181-ho-carole-2023-05-10 | NGM BIOPHARMACEUTICALS INC | 10 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 17:48 |
| DNLI | Denali Therapeutics Inc. | 15 Feb 2023 | 1 | -$43,394 | 4 | Chief Medical Officer | 17 Feb 2023, 15:20 |
| DNLI | Denali Therapeutics Inc. | 10 Feb 2023 | 2 | -$101,071 | 4 | Chief Medical Officer | 14 Feb 2023, 18:06 |
| DNLI | Denali Therapeutics Inc. | 08 Feb 2023 | 1 | -$46,968 | 4 | Chief Medical Officer | 10 Feb 2023, 17:12 |
| DNLI | Denali Therapeutics Inc. | 09 Jan 2023 | 1 | -$41,552 | 4 | Chief Medical Officer | 10 Jan 2023, 15:51 |
| DNLI | Denali Therapeutics Inc. | 05 Jan 2023 | 2 | -$116,568 | 4 | Chief Medical Officer | 09 Jan 2023, 20:43 |
| DNLI | Denali Therapeutics Inc. | 03 Jan 2023 | 3 | -$83,574 | 4 | Chief Medical Officer | 05 Jan 2023, 20:08 |
| BEAM | Beam Therapeutics Inc. | 01 Sep 2022 | 1 | $0 | 4 | Director | 02 Sep 2022, 16:05 |
| DNLI | Denali Therapeutics Inc. | 23 Aug 2022 | 1 | -$77,520 | 4 | Chief Medical Officer | 25 Aug 2022, 18:10 |
| DNLI | Denali Therapeutics Inc. | 19 Aug 2022 | 1 | -$85,575 | 4 | Chief Medical Officer | 23 Aug 2022, 16:45 |
| DNLI | Denali Therapeutics Inc. | 09 Aug 2022 | 1 | $0 | 4 | Chief Medical Officer | 11 Aug 2022, 19:22 |
| /report/000120919122031133-ho-carole-2022-05-18 | NGM BIOPHARMACEUTICALS INC | 18 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 18:22 |
| DNLI | Denali Therapeutics Inc. | 11 Feb 2022 | 1 | -$101,284 | 4 | Chief Medical Officer | 15 Feb 2022, 17:53 |
| DNLI | Denali Therapeutics Inc. | 09 Feb 2022 | 1 | -$52,791 | 4 | Chief Medical Officer | 11 Feb 2022, 16:16 |
| DNLI | Denali Therapeutics Inc. | 05 Jan 2022 | 1 | -$127,399 | 4 | Chief Medical Officer | 07 Jan 2022, 17:05 |
| DNLI | Denali Therapeutics Inc. | 03 Jan 2022 | 2 | $0 | 4 | Chief Medical Officer | 05 Jan 2022, 18:03 |
| DNLI | Denali Therapeutics Inc. | 06 Dec 2021 | 1 | -$62,760 | 4 | Chief Medical Officer | 08 Dec 2021, 16:35 |
| DNLI | Denali Therapeutics Inc. | 23 Aug 2021 | 1 | -$300,454 | 4 | Chief Medical Officer | 25 Aug 2021, 18:26 |
| DNLI | Denali Therapeutics Inc. | 19 Aug 2021 | 2 | -$126,230 | 4 | Chief Medical Officer | 23 Aug 2021, 20:25 |
| BEAM | Beam Therapeutics Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 07:57 |
| /report/000120919121039593-ho-carole-2021-06-08 | NGM BIOPHARMACEUTICALS INC | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 17:39 |